Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3367052 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL11154269 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL852296 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL5908153 | 0.89 | SRD5A2 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL7000399 | 0.89 | SRD5A2 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL11141410 | 0.88 | SRD5A1 (0.79) | SRD5A1SRD5A2 | |
| SCHEMBL11141415 | 0.88 | SRD5A1 (0.79) | SRD5A1SRD5A2 | |
| SCHEMBL11139621 | 0.87 | SRD5A1 (0.76) | SRD5A1SRD5A2 | |
| SCHEMBL11139619 | 0.87 | SRD5A1 (0.76) | SRD5A1SRD5A2 | |
| SCHEMBL9022351 | 0.85 | SRD5A1 (0.74) | SRD5A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2459187-B1 | COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH | OLSEN ELISE (US) | 2021-01-06 | — | — | EP | claimed |
| US-20190314259-A1 | COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH | DUKE UNIVERSITY | 2019-10-17 | — | — | US | claimed |
| EP-1175202-B3 | ANTI-DANDRUFF AND CONDITIONING SHAMPOOS CONTAINING POLYALKYLENE GLYCOLS AND CATIONIC POLYMERS | PROCTER & GAMBLE (US) | 2014-03-05 | — | — | EP | claimed |
| EP-1181008-B1 | ANTI-DANDRUFF AND CONDITIONING SHAMPOOS CONTAINING CERTAIN CATIONIC POLYMERS | PROCTER & GAMBLE (US) | 2011-06-22 | — | — | EP | claimed |
| EP-1175202-B1 | ANTI-DANDRUFF AND CONDITIONING SHAMPOOS CONTAINING POLYALKYLENE GLYCOLS AND CATIONIC POLYMERS | PROCTER & GAMBLE (US) | 2004-09-15 | — | — | EP | claimed |
| EP-1098626-B1 | METHOD FOR REGULATING HAIR GROWTH | UNIV TEXAS SOUTHWESTERN MED CT (US) | 2004-05-06 | — | — | EP | claimed |
| US-6649155-B1 | Cationic guar | THE PROCTER & GAMBLE COMPANY | 2003-11-18 | — | — | US | claimed |
| US-20030114526-A1 | Administration to a human for hair growth a formulation containing a compound selected from lupane triterpenes and derivatives, derivatives of oleanane triterpenes, derivatives of ursane derivatives or salts and mixtures; antialopecia | PROCTER & GAMBLE TO THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 2003-06-19 | — | — | US | claimed |
| US-6451777-B1 | Method for regulating hair growth | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 2002-09-17 | — | — | US | claimed |
| US-6451300-B1 | ANTI-DANDRUFF EFFICACY AND CONDITIONING, AND A METHOD OF CLEANSING AND CONDITIONING THE HAIR COMPRISING APPLYING TO THE HAIR AND SCALP AN EFFECTIVE AMOUNT OF SAID COMPOSITIONS. | THE PROCTER & GAMBLE COMPANY | 2002-09-17 | — | — | US | claimed |
| WO-1992021322-A1 | COSMETIC OR PHARMACEUTICAL, PARTICULARLY DERMATOLOGICAL, COMPOSITION CONTAINING A PRUNELLA EXTRACT | LVMH RECHERCHE (FR) | 1992-12-10 | — | — | WO | claimed |
| WO-1992016186-A1 | COSMETIC OR PHARMACEUTICAL, ESPECIALLY DERMATOLOGICAL, COMPOSITION,CONTAINING OXYACANTHINE, IN PARTICULAR FOR STIMULATING HAIR GROWTH OR RETARDING HAIR LOSS | LVMH RECHERCHE (FR) | 1992-10-01 | — | — | WO | claimed |
| WO-1992009262-A1 | USE OF MEDICAGO SAPONINS FOR THE PREPARATION OF COSMETIC OR PHARMACEUTICAL COMPOSITIONS, DERMATOLOGICAL COMPOSITIONS IN PARTICULAR, HELPING RENEW THE EPIDERMIS, STIMULATING REGROWTH OF HAIR, OR DELAYING HAIR LOSS | LVMH RECHERCHE (FR) | 1992-06-11 | — | — | WO | claimed |
| EP-0486595-A1 | SKIN PIGMENT COMPOSITION CONTAINING A COLEUS EXTRACT. | LVMH RECH (FR) | 1992-05-27 | — | — | EP | claimed |
| WO-1991002516-A1 | SKIN PIGMENT COMPOSITION CONTAINING A COLEUS EXTRACT | LVMH RECHERCHE (FR) | 1991-03-07 | — | — | WO | claimed |
| US-4885289-A | APPLYING ANTIANDROGEN TO SKIN | GILLETTE COMPANY | 1989-12-05 | — | — | US | claimed |
| EP-0004949-B1 | 4-AZA-17-SUBSTITUTED-5-ALPHA-ANDROSTAN-3-ONE, THEIR A AND D HOMO ANALOGS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MERCK & CO. INC. (US) | 1983-09-21 | — | — | EP | claimed |
| US-4377584-A | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors | MERCK & CO., INC. (US) | 1983-03-22 | — | — | US | claimed |
| US-4220775-A | Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors | MERCK & CO., INC. (US) | 1980-09-02 | — | — | US | claimed |
| EP-0004949-A1 | 4-Aza-17-substituted-5-alpha-androstan-3-one, their A and D homo analogs, process for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1979-10-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114526-A1 | Administration to a human for hair growth a formulation containing a compound selected from lupane triterpenes and derivatives, derivatives of oleanane triterpenes, derivatives of ursane derivatives or salts and mixtures; antialopecia | LSS, CUTA, NR5A1 | SRD5A1 47/4885SRD5A2 26/4885 |
| US-20190314259-A1 | COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH | PTGIR, MC1R, PTGFR | SRD5A1 374/4885SRD5A2 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.